Cargando…

Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019

As the coronavirus disease 2019 (COVID-19, also called severe acute respiratory syndrome coronavirus-2) outbreak accelerates, vigorous and diverse efforts were made in developing treatment strategies. In addition to direct acting agents, increasing evidence showed some potential adjuvant therapies w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kuan-Hsuan, Wang, Sheng-Fan, Wang, Szu-Yu, Yang, Yi-Ping, Wang, Mong-Lien, Chiou, Sih-Hwa, Chang, Yuh-Lih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434021/ https://www.ncbi.nlm.nih.gov/pubmed/32568969 http://dx.doi.org/10.1097/JCMA.0000000000000375

Ejemplares similares

The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2
por: Wang, Sheng-Fan, et al.
Publicado: (2020)

Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis
por: Jiang, Bo-Hua, et al.
Publicado: (2015)

Hunting coronavirus severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research
por: Yang, De-Ming, et al.
Publicado: (2020)

Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19)
por: Li, Sheng-De, et al.
Publicado: (2021)

Targeting cancer stem cells: emerging role of Nanog transcription factor
por: Wang, Mong-Lien, et al.
Publicado: (2013)

Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemic
por: Chen, Chun-Fan, et al.
Publicado: (2020)

Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study
por: Hong, Wenxin, et al.
Publicado: (2020)

Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
por: Song, Hui-Yung, et al.
Publicado: (2019)

Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease
por: Song, Hui-Yung, et al.
Publicado: (2016)

Potential therapeutic agents against COVID-19: What we know so far
por: Lu, Chih-Chia, et al.
Publicado: (2020)

Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Tsai, Ping-Hsing, et al.
Publicado: (2020)

Pharmacologic Treatment and Management of Coronavirus Disease 2019
por: Shumaker, Amy Hirsch, et al.
Publicado: (2022)

Overview of coronavirus disease 2019: Treatment updates and advances
por: Luo, Yung-Hung, et al.
Publicado: (2020)

Potential Anti-Coronavirus Agents and the Pharmacologic Mechanisms
por: Yang, Yang, et al.
Publicado: (2021)

Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
por: Torrinhas, Raquel S., et al.
Publicado: (2021)

Pharmacological and non-pharmacological strategies in coronavirus disease 2019: A literature review
por: González-Ruiz, Francisco J.
Publicado: (2022)

Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia
por: McManus, Dayna, et al.
Publicado: (2023)

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan
por: Luo, Yung-Hung, et al.
Publicado: (2022)

Novel biosensor platforms for the detection of coronavirus infection and severe acute respiratory syndrome coronavirus 2
por: Liang, Kung-Hao, et al.
Publicado: (2020)

Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings
por: Pan, Chih-Ming, et al.
Publicado: (2016)

Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)

Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer
por: Luo, Yung-Hung, et al.
Publicado: (2021)

Effective strategies to prevent in-hospital infection in the emergency department during the novel coronavirus disease 2019 pandemic
por: Kung, Chia-Te, et al.
Publicado: (2021)

Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
por: Xiang, Hui, et al.
Publicado: (2022)

Use of sedative pharmacological agents among biomedical students during the coronavirus disease 2019 pandemic: a cross-sectional pilot study
por: Burja Vladić, Monika, et al.
Publicado: (2022)

Vitamin D: an essential adjuvant therapeutic agent in breast cancer
por: Thabet, Romany H, et al.
Publicado: (2022)

The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents
por: Coll-Martínez, Bernat, et al.
Publicado: (2020)

American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting Pre‐Conferences
por: Bai, Jane P.F., et al.
Publicado: (2019)

Exploring the potential therapeutic effect of traditional Chinese medicine on coronavirus disease 2019 (COVID-19) through a combination of data mining and network pharmacology analysis
por: Sun, Xiuli, et al.
Publicado: (2020)

Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
por: Zhang, Jinnong, et al.
Publicado: (2020)

Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease
por: Hsu, Chia-Chen, et al.
Publicado: (2023)

Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology
por: Du, Hai-Xia, et al.
Publicado: (2021)

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
por: Ning, Qin, et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
por: Goodarzi, Pedram, et al.
Publicado: (2020)

Familial clusters of the 2019 novel coronavirus diseases in Taiwan
por: Dai, Chia-Yen, et al.
Publicado: (2020)

Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19
por: Chen, Chun-Fan, et al.
Publicado: (2020)

Adipose-Derived Stem Cell Exosomes as a Novel Anti-Inflammatory Agent and the Current Therapeutic Targets for Rheumatoid Arthritis
por: Chang, Ting-Hui, et al.
Publicado: (2022)

Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling
por: Wu, Szu‐Yuan, et al.
Publicado: (2017)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019
por: Wang, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9m1mubrobs69g9q3de9el1pp4b